SURGERY
As is well-known, only since the 1870's has curative medicine been sufficiently effective to become a dramatic, positive force in shaping human history, and surgery was first to enjoy conspicuous success which depended on three major discoveries: (1) anesthesia; (2) cellular pathology; and (3) antiseptic surgery. The last two events manifestly sprang from concepts of atomicity, but the discovery of anesthesia did not. Here is the one exception to a principal innovation having been based on atomicity.
In 1858 But it was not cell theory alone that influenced Virchow, for E. H. Ackerknecht has shown that Virchow's democratic politics reinforced his biological thinking.6 For Virchow, the body was a free, democratic state of equal, individual cells. Moreover, nineteenth-century democratic thought must have influenced other ideas of atomicity; such social tenets certainly provided a receptive milieu for atomistic concepts. Pooh Bah in Gilbert and Sullivan's Mikado bore witness to popular acceptance of cellular atomism in 1884 when he claimed, "I can trace my ancestry back to a protoplasmal primordial atomic globule."
The importance of cellular pathology for surgery was that it localized disease. Humoralistic concepts had spread the causes of disease throughout the body, whereas cellular pathology emphasized local causes. Surgical extirpation of diseased tissue, particularly tumors, was senseless according to humoral doctrine. But localized cellular pathology rationalized surgical intervention, and, immensely stimulated the development of operative surgery in the 1870's. Indeed, Joseph Lister, eminent surgeon and author of the third eventful innovation-the antiseptic system-required to make modern surgery possible, stated in 1870, "While thus adopting the language of 'Cellular Pathology,' elaborated by Virchow and others following the path first opened up by Goodsir, I may remark that my own experience has tended to convince me of the truth of that doctrine."7
Like cellular pathology, the invention of surgical antisepsis was clearly based on an idea of atomicity. Louis Pasteur, trained as a chemist, elaborated his theory of the germ origin of disease in the years following 1857, but by 1865 he had not demonstrated the germ theory in either man or beast. Nevertheless, on the basis of his research on fermentation, Pasteur preached that specific microorganisms were indivisible units causing specific diseases-an idea most congenial to a chemist brought up on the chemical theory of the atom. It was in 1865 that another chemist, Thomas
Anderson, brought to Lister's attention Pasteur's papers on fermentation and putrefaction. Lister's own studies had led him to believe and teach that putrefaction caused wound infection, the eradication of which was a goal he vigorously pursued.
Lister read in Pasteur's publications that putrefaction was a form of fermentation caused by microorganisms which could be found on dust particles floating about in air. Reasoning that these "germs of various low forms of life" caused infection on gaining access to wounds, and being struck with an account of the remarkable effects produced by carbolic acid upon the sewage of the town of Carlisle,8 Lister undertook the treatment of compound fractures with carbolic acid dressings. The antiseptic successfully destroyed the invaders in most cases-a remarkable finding which appeared in Lister's classic paper of 1867 following which surgery rapidly became the first medical specialty to treat effectively a broad series of diseases.
ENDOCRINE AND METABOLIC DISEASES
Although various investigators at the turn of the century successfully participated in the isolation and identification of epinephrine, it was not until 1905 that E. H. Starling presented an integrated view of endocrine function in his "Croonian Lectures on the Chemical Correlation of the Functions of the Body"' wherein he was the first to propose that "these Chemical messengers" be called "hormones. " Starling conceived of hormones atomistically as being indivisible units of communication-as being molecules having specific biological action which might be altered by slight changes "such as the introduction or withdrawal of an ethyl, methyl, or NH2 group."
In 1912, Casimir Funk published his historic paper, "The Etiology of the Deficiency Diseases"' in which he reviewed his and other work, and persuasively proposed a new disease concept-deficiency disease. He brought together for the first time beriberi, scurvy, rickets, and tentatively, pellagra into a deficiency disease grouping, and called the deficient substances "vitamines" since he believed them to be amines. Funk thought of his vitamines in biological terms so that once again a molecule was an indivisible unit of action-this time as an accessory food factor. When Starling and Funk published their articles, empirical treatment had been developed for several endocrine and metabolic diseases -notably, myxedema, scurvy, and rickets. However, only epinephrine and no vitamins had been chemically identified, but hormones and vitamins were rapidly isolated following 1912. As knowledge of these substances and their activities became available, it was possible to prevent and control an increasingly large number of diseases, and this second significant success of curative medicine depended directly on two ideas of atomicity-hormones and vitamins.
CORPORA NON AQUNT NISI FIXATA "If for chemistry the law applies: corpora non aqunt nisi liquida, then: corpora non aqunt nisi fixata is appropriate for chemotherapy !"' So wrote Paul Ehrlich in his "Concluding Remarks" to the famous book he and S. Hata published in 1910, wherein they reported on the new drug dioxydiamidoarsenobenzol (592) and its hydrochlorate salt called 606 or salvarsan-the first widely used, laboratory-created, systemic chemotherapeutic agent. There had been earlier successful attacks on microorganisms beginning with quinine in the seventeenth century, when there was no understanding of the mechanisms involved, but they had been few. Von Behring's serum therapy of the early 1890's and Ehrlich's trypan red of 1904 had also been conspicuous achievements.
The basic theories that led Ehrlich to discover salvarsan were atomistic in nature. First he subscribed to Pasteur's theory of the germ origin of infectious disease with its microorganisms the indivisible disease agents, and on a stereochemical basis, he conceived of these microbes as having "chemoceptors" capable of anchoring certain molecules to the cell. Second he thought of molecules as having unique properties including affinity for a pathogen's chemoceptor and at the same time being a poison or an inhibitor to the pathogen but non-toxic to the host. He further realized that slight changes in molecular structure and composition could produce large changes in curative and toxic activity.
Despite its grand derivation from two Latin words meaning "to preserve health," salvarsan possessed sharply limited therapeutic application. Nevertheless, by employing two atomistic concepts, Ehrlich had revealed a totally novel course of attack on infectious disease and, of equal importance, condlitioned men's minds to the probable existence of additional systemic chemotherapeutic agents.
Still, it required a quarter of the twentieth century to begin to mount a general attack, for it was not until 1935 that Gerhard Domagk announced his discovery of Prontosil, the first of the sulfonamides. Unlike salvarsan, these drugs had a wide variety of clinical applications. The two ideas of atomicity which underlay Ehrlich's work also motivated Domagk's research which, however, did not involve "purposeful synthetic work." Rather, Domagk empirically screened a number of previously synthesized compounds for possible bacteriostatic or bacteriocidal activity. French biochemists soon showed that the chemotherapeutically active component of Prontosil was sulfanilamide, first synthesized by Paul Gelmo in 1908, the year following Alfred Bertheim's synthesis of salvarsan under Ehrlich's direction.
If the chemical planning which led to Domagk's discovery had been slight, planning associated with the discovery of penicillin, product of a fungus, was quite lacking, for as is well-known, Sir Alexander Fleming's finding was accidental. S. J. Woolf once quoted Fleming as having said that he "was always on the lookout for antibiotics,"' and indeed, his earlier discovery of lysozyme had been equally accidental. Undoubtedly, Ehrlich's chemotherapeutic ideas conditioned Fleming's being always on the lookout, and as Sir Howard Florey, leader of the research team which developed penicillin into a powerful systemic chemotherapeutic agent, has recently written, "some antibiotics are novel in the sense that their differential toxicity, as between bacterium and host, is very great, but the introduction of antibiotics into practical medicine did not either stem from or result in the enunciation of any new principles affecting medicine."'
The outbreak of the Second World War, together with R. J. Dubos' discovery of tyrothricin, stimulated Selman A. Waksman to plunge into an investigation of the effects of soil microorganisms on pathogenic bacteria.1' Waksman's research was guided by effective biological planning and by principles of chemotherapy. Indeed, during 1918-1920 at the start of his scientific career, Waksman had worked for a drug firm, performing biological tests for toxicity of each batch of salvarsan produced.' In April 1940, he pointed out at the National Academy of Sciences that bacteriologists in the 1880's had asked what had become of all the bacterial pathogens for men and animals that had found their way into the soil, either in the excreta of the hosts or in their remains, and added that a search of the soil having shown that such bacteria do not survive there long, it had been suggested that soil-inhabiting microorganisms effected the destruction of the pathogens.'6 In the same paper Waksman and Woodruff described the powerfully antibiotic but extremely toxic actinomycin derived from an actinomycete, and in 1944 Waksman and his collaborators introduced streptomycin from the actinomycete Streptomyces griseus-the first actinomycete antibiotic to be a potent systemic chemotherapeutic agent. Subsequently, investigators have screened literally tens of thousands of actinomycete strains from which have come all useful antibiotics except for penicillin, tyrothricin, bacitracin, fumagillin and the polymyxins.
Thus Pasteur's and Ehrlich's atomistic concepts have been the basis on which Ehrlich, Domagk, Fleming, Florey, Waksman, and their collaborators fashioned the twentieth century's conquest of infectious disease.
In summary, the scientific concept of atomicity underlies the three successful advances of curative medicine in the last hundred years with the important exception that it did not play a role in the introduction of anesthesia. Atomicity provides a unity to the new curative medicine, and its immense success suggests that it may yield still further triumphs in the future.
